Mistrial Declared In First Androgel Bellwether
The first attempt to bring AbbVie Inc. to trial over the allegedly hidden side effects of its testosterone replacement drug Androgel ended in a mistrial Monday after the lead plaintiff's attorney...To view the full article, register now.
Already a subscriber? Click here to view full article